Pine Ridge Advisers’s Roivant Sciences ROIV Stock Holding History

Pine Ridge Advisers’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.66M	Hold	276,530	–	–	0.47%	23
2025 Q4	$6M	Hold	276,530	–	–	0.36%	27
2025 Q3	$4.18M	Hold	276,530	–	–	0.25%	27
2025 Q2	$3.12M	Hold	276,530	–	–	0.2%	33
2025 Q1	$2.79M	Hold	276,530	–	–	0.24%	29
2024 Q4	$3.27M	Hold	276,530	–	–	0.29%	27
2024 Q3	$3.19M	Hold	276,530	–	–	0.32%	28
2024 Q2	$2.92M	Buy	+276,530	New	+$3.03M	0.31%	26

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Pine Ridge Advisers's ROIV Position: Q1 2026 in Review

Pine Ridge Advisers held its Roivant Sciences (ROIV) position steady in Q1 2026 at 276,530 shares worth $7.66M. The position accounts for 0.47% of the portfolio, ranked #23.

Pine Ridge Advisers first reported a position in ROIV in Q2 2024 and has held it in 8 quarters since. 439 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

Pine Ridge Advisers held 276,530 shares of Roivant Sciences worth $7.66M as of Q1 2026.
Pine Ridge Advisers left its Roivant Sciences share count unchanged in Q1 2026.
Roivant Sciences made up 0.47% of Pine Ridge Advisers's portfolio in Q1 2026, its #23 holding.
Pine Ridge Advisers first reported a position in Roivant Sciences in Q2 2024 and has held it in 8 quarters since.
439 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Pine Ridge Advisers's 13F filing for Q1 2026, filed 18 May 2026.